Homology Medicines, Inc.

NasdaqGS:FIXX Stock Report

Market Cap: US$54.3m

Homology Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of FIXX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies00%
Individual Insiders414,1920.712%
Public Companies5,000,0008.6%
Institutions8,408,02714.5%
VC/PE Firms15,955,60927.4%
General Public28,355,71248.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 49.98% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.92%
Arch Venture Partners, L.P.
5,768,694US$5.4m0%0.35%
9.72%
Temasek Holdings (Private) Limited
5,650,996US$5.3m0%0.01%
8.6%
Pfizer Inc.
5,000,000US$4.7m0%no data
7.8%
5AM Venture Management, LLC
4,535,919US$4.2m0%0.75%
3.34%
The Vanguard Group, Inc.
1,939,590US$1.8m-5.22%no data
2.41%
Newtyn Management, LLC
1,399,260US$1.3m0%0.17%
1.88%
BlackRock, Inc.
1,090,113US$1.0m-1.46%no data
1.29%
BML Capital Management, LLC
748,108US$699.3k0%0.49%
0.64%
Vivo Capital, LLC
370,068US$345.9k0%0.02%
0.56%
Geode Capital Management, LLC
323,459US$302.3k0%no data
0.53%
George Kaiser Family Foundation, Endowment Arm
306,514US$286.5k680%0.06%
0.52%
U.S. Global Investors, Inc.
303,679US$283.8k0%0.01%
0.51%
ADAR1 Capital Management, LLC
293,676US$274.5k0%0.11%
0.31%
Albert Seymour
181,879US$170.0k1.86%no data
0.3%
Renaissance Technologies LLC
174,600US$163.2k-3%no data
0.27%
Merrill Lynch & Co. Inc., Banking Investments
159,803US$149.4k-42.9%no data
0.23%
State Street Global Advisors, Inc.
133,804US$125.1k0%no data
0.22%
Arthur Tzianabos
128,778US$120.4k18.8%no data
0.2%
Tudor Investment Corporation
115,623US$108.1k0%no data
0.17%
Susquehanna International Group, LLP, Asset Management Arm
99,081US$92.6k-14.1%no data
0.12%
Citadel Advisors LLC
69,183US$64.7k-92.1%no data
0.11%
Acadian Asset Management LLC
66,515US$62.2k-48.9%no data
0.11%
FMR LLC
66,312US$62.0k4.41%no data
0.11%
Northern Trust Global Investments
65,762US$61.5k0%no data
0.11%
Oup Management Co., LLC
64,000US$59.8k0%0.11%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/03/26 12:40
End of Day Share Price 2024/03/25 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Homology Medicines, Inc. is covered by 12 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu KumarBaird
Jason ZemanskyBofA Global Research
Madhu KumarB. Riley Securities, Inc.